Finance

Beta
Lists
VEEV:NYSE
Veeva Systems Inc
$171.36
+8.40%
(+13.28) 1D
$170.52
-0.49% (-0.84)
After hours
Closed: Jun 26, 4:02:08 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VEEV...
Open
$160.25
High
$171.49
Low
$160.25
Mkt. cap
27.84B
Avg. vol.
2.66M
Volume
5.66M
P/E ratio
30.31
52-wk high
$310.50
52-wk low
$148.05
EPS
$5.65
Beta
0.95
Shares outstanding
162.44M
No. of employees
8K
Open
$160.25
High
$171.49
Low
$160.25
Mkt. cap
27.84B
Avg. vol.
2.66M
Volume
5.66M
P/E ratio
30.31
52-wk high
$310.50
52-wk low
$148.05
EPS
$5.65
Beta
0.95
Shares outstanding
162.44M
No. of employees
8K
News stories
From sources across the web
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing. The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Its primary competitor for its customer relationship management software is Salesforce, which is partnered with IQVIA. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7.93K
Founded2007
HeadquartersPleasanton, California, United States
SectorHealth care
Websiteveeva.com
Analyst ratings
Based on 22 analysts giving stock ratings to VEEV in the past 3 months
Buy
Buy
15
Hold
6
Sell
1
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for VEEV in the last 3 months.
Highest
Current $171.36
$340.00 (+98.41%)
Average
$238.45 (+39.15%)
Lowest
$165.00 (-3.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alexei Gogolev
J.P. Morgan
Buy
Maintained
$272.00
+58.7%
06/25/2026
Dylan Becker
William Blair
Buy
Maintained
-
-
06/23/2026
Stan Berenshteyn
Wells Fargo
Buy
Maintained
$320.00
+86.7%
06/10/2026
Steven Valiquette
Mizuho Securities
Buy
Maintained
$270.00
+57.6%
06/03/2026
Sean Dodge
BMO Capital
Hold
Maintained
$175.00
+2.1%
06/03/2026
Charles Rhyee
TD Cowen
Buy
Maintained
$235.00
+37.1%
06/04/2026
David Grossman
Stifel Nicolaus
Buy
Reiterated
$230.00
+34.2%
06/04/2026
Martin Yang
Oppenheimer
Buy
Reiterated
$225.00
+31.3%
06/04/2026
Kenneth Wong
Oppenheimer
Buy
Reiterated
$225.00
+31.3%
06/04/2026
Kirk Materne
Evercore ISI
Hold
Maintained
$185.00
+8%
06/04/2026
Karl Keirstead
UBS
Hold
Reiterated
$190.00
+10.9%
06/04/2026
Joseph Vruwink
Robert W. Baird
Buy
Maintained
$260.00
+51.7%
06/04/2026
David Hynes
Canaccord Genuity
Hold
Maintained
$220.00
+28.4%
06/04/2026
Craig Hettenbach
Morgan Stanley
Hold
Maintained
$215.00
+25.5%
06/04/2026
Hannah Rudoff
Piper Sandler
Buy
Maintained
$235.00
+37.1%
06/04/2026
David Larsen
BTIG
Buy
Reiterated
$340.00
+98.4%
06/03/2026
Adam Hotchkiss
Goldman Sachs
Sell
Maintained
$165.00
-3.7%
06/04/2026
Tyler Radke
Citi
Hold
Maintained
$190.00
+10.9%
06/03/2026
Ryan MacDonald
Needham
Buy
Reiterated
$270.00
+57.6%
06/04/2026
Saket Kalia
Barclays
Buy
Reiterated
$235.00
+37.1%
06/04/2026
Rishi Jaluria
RBC Capital
Buy
Maintained
$275.00
+60.5%
06/04/2026
Brian Peterson
Raymond James
Buy
Maintained
-
-
06/03/2026
Jailendra Singh
Truist Financial
Buy
Maintained
$262.00
+52.9%
06/04/2026
Unknown Analyst
Stephens
Buy
Maintained
$324.00
+89.1%
03/05/2026
Bradley Sills
Bank of America Securities
Hold
Maintained
$304.00
+77.4%
03/04/2026
Last report
Jun 3, 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
$2.24 / $2.14
+4.91%beat
Revenue / Est. (USD)
882.95M / 857.73M
+2.94%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
789.08M
811.24M
835.95M
882.95M
Cost of goods sold
195.25M
199.46M
213.48M
220.92M
Cost of revenue
195.25M
199.46M
213.48M
220.92M
Research and development expenses
192.68M
191.88M
198.79M
208.32M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
174.62M
179.04M
177.80M
180.59M
Operating expense
367.29M
370.92M
376.60M
388.91M
Total operating expenses
562.55M
570.38M
590.08M
609.84M
Operating income
226.54M
240.85M
245.88M
273.11M
Other non operating income
69.46M
-
934.00K
-
EBT including unusual items
265.36M
312.79M
317.54M
347.53M
EBT excluding unusual items
295.99M
312.79M
315.70M
345.74M
Income tax expense
65.06M
76.58M
73.33M
86.59M
Effective tax rate
24.52%
24.48%
23.09%
24.92%
Other operating expenses
-
-
-
-
Net income
200.31M
236.20M
244.20M
260.94M
Net profit margin
25.39%
29.12%
29.21%
29.55%
Earnings per share
1.99
2.04
2.06
2.24
Interest and investment income
-
71.93M
74.35M
70.63M
Interest expense
-
-
-
-
Net interest expenses
-
71.93M
74.35M
70.63M
Depreciation and amortization charges
-
-
-
-
EBITDA
236.66M
250.56M
254.19M
284.70M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of VEEV
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer